HRS9531 Clinical Trials
5 recruitingDrug
Phase 34Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease
Fujian Shengdi Pharmaceutical Co., Ltd.9,262 enrolled1 locationNCT07551492
Recruiting
Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy
Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy
Fujian Shengdi Pharmaceutical Co., Ltd.140 enrolled1 locationNCT06994650
Recruiting
Phase 3
Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd.300 enrolled1 locationNCT07060456
Recruiting
Phase 3
A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity
Bstructive Sleep Apnea (OSA) and Obesity
Fujian Shengdi Pharmaceutical Co., Ltd.140 enrolled1 locationNCT06974851
Recruiting
Phase 1
A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd.32 enrolled1 locationNCT06246175